Stockreport

ReShape Lifesciences' (RSLS) CEO Dan Gladney on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]

ReShape Lifesciences, Inc.  (RSLS) 
US:NASDAQ Investor Relations: ir.enteromedics.com
PDF ReShape Lifesciences Inc. (NASDAQ: RSLS ) Q1 2018 Earnings Conference Call May 14, 2018 4:30 PM ET Executives Dan Gladney - Chairman & CEO Scott Youngstrom [Read more]